In vitro oxidative metabolism study of (-)-rhazinilam

Bioorg Med Chem. 2006 Mar 1;14(5):1558-64. doi: 10.1016/j.bmc.2005.10.015. Epub 2005 Oct 27.

Abstract

Metabolism studies were conducted in order to investigate the reasons for the in vivo lack of activity of (-)-rhazinilam 1, an original poison of the mitotic spindle. Bioconversion by Beauveria bassiana strains, rat and human liver microsomes allowed the identification of metabolites 2, 3, and 4 oxidized in positions 3 and 5 of rhazinilam. Further experiments indicated that CYP2B6 was the main CYP responsible for the oxidation of 1 by human liver microsomes. All isolated metabolites were markedly less active than rhazinilam in vitro, which might explain its in vivo inactivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / metabolism*
  • Alkaloids / pharmacology
  • Animals
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Biotransformation
  • Cordyceps / drug effects*
  • Cordyceps / growth & development
  • Crystallography, X-Ray
  • Cytochrome P-450 CYP2B6
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Indolizines / metabolism
  • Indolizines / pharmacology
  • Lactams / metabolism
  • Lactams / pharmacology
  • Microsomes, Liver / enzymology
  • Oxidation-Reduction
  • Oxidoreductases, N-Demethylating / metabolism
  • Rats
  • Spindle Apparatus / metabolism
  • Time Factors

Substances

  • Alkaloids
  • Antineoplastic Agents
  • Indolizines
  • Lactams
  • rhazinilam
  • Aryl Hydrocarbon Hydroxylases
  • CYP2B6 protein, human
  • Cytochrome P-450 CYP2B6
  • Oxidoreductases, N-Demethylating